Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

IDH2 R172K

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Related tests:

Abbott RealTime IDH2 (1)

Abbott RealTime IDH2 (1)

IDH2 R172K	Acute Myelogenous Leukemia	IDH2 R172K	Acute Myelogenous Leukemia	selinexor Sensitive: C3 – Early Trials selinexor Sensitive : C3	selinexor Sensitive: C3 – Early Trials selinexor Sensitive : C3
IDH2 R172K	Acute Myelogenous Leukemia	IDH2 R172K	Acute Myelogenous Leukemia	venetoclax + enasidenib Sensitive: C3 – Early Trials venetoclax + enasidenib Sensitive : C3	venetoclax + enasidenib Sensitive: C3 – Early Trials venetoclax + enasidenib Sensitive : C3
IDH2 R172K	Acute Myelogenous Leukemia	IDH2 R172K	Acute Myelogenous Leukemia	TQB3455 Sensitive: C3 – Early Trials TQB3455 Sensitive : C3	TQB3455 Sensitive: C3 – Early Trials TQB3455 Sensitive : C3
IDH2 R172K	Acute Myelogenous Leukemia	IDH2 R172K	Acute Myelogenous Leukemia	venetoclax Sensitive: C4 – Case Studies venetoclax Sensitive : C4	venetoclax Sensitive: C4 – Case Studies venetoclax Sensitive : C4
IDH2 R172K	Cholangiocarcinoma	IDH2 R172K	Cholangiocarcinoma	ponatinib Sensitive: D – Preclinical ponatinib Sensitive : D	ponatinib Sensitive: D – Preclinical ponatinib Sensitive : D
IDH2 R172K	Cholangiocarcinoma	IDH2 R172K	Cholangiocarcinoma	bosutinib Sensitive: D – Preclinical bosutinib Sensitive : D	bosutinib Sensitive: D – Preclinical bosutinib Sensitive : D
IDH2 R172K	Cholangiocarcinoma	IDH2 R172K	Cholangiocarcinoma	AZD0530 Sensitive: D – Preclinical AZD0530 Sensitive : D	AZD0530 Sensitive: D – Preclinical AZD0530 Sensitive : D
IDH2 R172K	Cholangiocarcinoma	IDH2 R172K	Cholangiocarcinoma	dasatinib Sensitive: D – Preclinical dasatinib Sensitive : D	dasatinib Sensitive: D – Preclinical dasatinib Sensitive : D